User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Sinonasal involvement as a rare extraintestinal manifestation of Crohn's disease.

Primary tabs

Eloy, Philippe [UCL] Leruth, Elisabeth Goffart, Y Nollevaux, Marie-Cécile [UCL] Fridman, V Melange, Michel [UCL] Daele, Jean-Michel [UCL] Bertrand, Bernard [UCL]

Crohn's disease is a chronic idiopathic slowly developing transmural inflammation of the digestive system. It usually involves the small intestine and/or the area around the anus but can also affect the entire gastrointestinal tract anywhere from the mouth to the anus. Extra intestinal manifestations occur frequently and multiple organ systems may be affected: the skin, joints, spine, eyes, liver and bile ducts. In contrast, nasal manifestations are extremely rare and only a few cases have been reported up to date in the worldwide literature. The authors report two cases with nasal manifestations concomitant to intestinal Crohn's disease and go over the relevant literature on such an association.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2007
Journal information "European Archives of Oto-Rhino-Laryngology" - Vol. 264, no. 1, p. 103-108 (2007)
Peer reviewed yes
Publisher Springer International ((Germany) Heidelberg)
issn 0937-4477
e-issn 1434-4726
Publication status Publié
Affiliations UCL - MD/NOPS - Département de neurologie et de psychiatrie
UCL - MD/IEPR - Institut d'éducation physique et de réadaptation
UCL - (MGD) Service d'oto-rhino-laryngologie
UCL - (MGD) Service d'anatomie pathologique
UCL - (MGD) Service de gastro-entérologie
UCL - MD/MINT - Département de médecine interne
UCL - (SLuc) Centre de l'allergie
MESH Subject Acute Disease ; Adolescent ; Adult ; Anti-Infective Agents - therapeutic use ; Crohn Disease - complications - diagnosis - drug therapy ; Diagnosis, Differential ; Ethmoid Sinusitis - complications ; Female ; Humans ; Sulfasalazine - therapeutic use ; Voice Disorders - complications - diagnosis
Keywords Crohn's disease ; Nasal involvement ; Acute ethmoiditis ; Laryngeal ulceration
Links
  1. Abrams J., Der Larynx - ein weiteres Manifestationsorgan des Morbus Crohn, 10.1055/s-2007-998225
  2. Ahmad Ishfaq, Owens David, Granulomatous Cheilitis and Crohn's Disease, 10.1155/2001/602183
  3. Aufses AH Jr (2001) The history of Crohn’s disease. Surg Clin North Am 81(1):1–11
  4. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96(4):1116–1122
  5. Bradley PJ, Ferlito A, Devaney KO, Rinaldo A (2004) Crohn’s disease manifesting in the head and neck. Acta Otolaryngol 124(3):237–241
  6. Coenen C, Borsch G, Muller KM, Fabry H (1988) Oral inflammatory changes as an initial manifestation of Crohn’s disease antedating abdominal diagnosis. Report of a case. Dis Colon Rectum 31(7):548–552
  7. Cosnes J (2004) Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18(3):481–496
  8. Emerit J, Congy F, Loeper J (1982) Recent data on the epidemiology and etiology of Crohn’s disease. Nouv Presse Med 11(43):3195–3200
  9. Ernst A, Preyer S, Plauth M, Jenss H (1993) Polypoid pansinusitis in an unusual, extra-intestinal manifestation of Crohn disease. HNO 41(1):33–36
  10. Ferjaoui M, Kooli H, Najeh D, Hajri H (1999) Nasal localization of the Crohn’s disease. Rev Laryngol Otol Rhinol (Bord) 120(5):341–342
  11. Field EA, Tydesley WR (1989) Oral Crohn’s disease revisited—a 10-year-review. Br J Oral Maxillofac Surg 27(2):114–123
  12. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115(1):182–205
  13. Friedman S, Blumberg RS (2001) Inflammatory bowel disease. In: Braunwald E (ed) Harrison’s principles of internal medicine, vol 2, 15th edn. McGraw-Hill Professional Publishing, pp 1679–1691
  14. Ghandour K, Issa M (1991) Oral Crohn’s disease with late intestinal manifestations. Oral Sur Oral Med Oral Pathol 72(5):565–567
  15. Gianoli GJ, Miller RH (1994) Crohn’s disease of the larynx. J Laryngol Otol 108(7):596–598
  16. Girlich C, Bogenrieder T, Palitzsch KD, Scholmerich J, Lock G (2002) Orofacial granulomatosis as initial manifestation of Crohn’s disease: a report of two cases. Eur J Gastroenterol Hepatol 14(8):873–876
  17. Halme L, Meurman JH, Laine P, von Smitten K, Syrjanen S, Lindqvist C, Strand-Pettinen I (1993) Oral findings in patients with active or inactive Crohn’s disease. Oral Surg Oral Med Oral Pathol 76(2):175–181
  18. Halme LE (1992) Results of surgical treatment of patients with Crohn’s disease. Ann Chir Gynaecol 81(3):277–283
  19. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z (2000) The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 35(3):154–167
  20. Kaufman I, Caspi D, Yeshurun D, Dotan I, Yaron M, Elkayam O (2005) The effect of infliximab on extraintestinal manifestations of Crohn’s disease. Rheumatol Int 25(6):406–410
  21. Kinnear WJ (1985) Crohn’s disease affecting the nasal mucosa. J Otolaryngol 14(6):399–400
  22. Kriskovich MD, Kelly SM, Jackson WD (2000) Nasal septal perforation: a rare extraintestinal manifestation of Crohn’s disease. Ear Nose throat J 79(7):520–523
  23. Lindberg E, Jarnerot G, Huitfeldt B (1992) Smoking in Crohn’s disease: effect on localisation and clinical course. Gut 33(6):779–782
  24. Loch WE, Reiriz HM (1978) Acute necrotizing rhinitis in man. Rhinology 16(4):235–242
  25. MacDonald TT, DiSabatino A, Gordon JN (2005) Immunopathogenesis of Crohn’s disease. JPEN J Parenter Enteral Nutr 29(4 Suppl):S118–S124; discussion S124–S125, S184–S188
  26. Malins TJ, Wilson A, Ward-Booth RP (1991) Recurrent buccal space abscesses: a complication of Crohn’s disease. Oral Surg Oral Med Oral Pathol 72(1):19–21
  27. Merkonidis C, Verma S, Salam MA (2005) Saddle nose deformity in a patient with Crohn’s disease. J Laryngol Otol 119(7):573–576
  28. Michetti P, Juillerat P, Mottet C, Gonvers JJ, Burnand B, Vader JP, Froelich F, Felley C (2005) Therapy of mild to moderate luminal Crohn’s disease. Digestion 71(1):13–18
  29. Murray JJ (1998) Controversies in Crohn’s disease. Baillieres Clin Gastroenterol 12(1):133–155
  30. Ottaviani Francesco, Schindler Antonio, Petrone Mara, Capaccio Pasquale, Porro Gabriele Bianchi, New Therapy for Orolaryngeal Manifestations of Crohn's Disease, 10.1177/000348940311200108
  31. Panaccione R, Ferraz JG, Beck P (2005) Advances in medical therapy of inflammatory bowel disease. Curr Opin Pharmacol 5(6):566–572
  32. Pittock S, Drumm B, Fleming P, McDermott M, Imrie C, Flint S, Bourke B (2001) The oral cavity in Crohn’s disease. J Pediatr 138(5):767–771
  33. Plauth M, Jenss H, Meyle J (1991) Oral manifestations of Crohn’s disease. An analysis of 79 cases. J Clin Gastroenterol 13(1):29–37
  34. Pochon N, Dulguerov P, Widgren S (1995) Nasal manifestations of Crohn’s disease. Otolaryngol Head Neck Surg 113(6):813–815
  35. Present Daniel H., Korelitz Burton I., Wisch Nathaniel, Glass Joseph L., Sachar David B., Pasternack Bernard S., Treatment of Crohn's Disease with 6-Mercaptopurine : A Long-Term, Randomized, Double-Blind Study, 10.1056/nejm198005013021801
  36. Present DH, Rutgeerts P, Targan S (1999) Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med 340(18):1398–1405
  37. Rispo A, Scarpa R, di Girolamo E, Cozzolino A, Lembo G, Atteno M, De Falco T, Lo Presti M, Castiglione F (2005) Infliximab in the treatment of extra-intestinal manifestations of Crohn’s disease. Scand J Rheumatol 34(5):387–391
  38. Rowe PH, Taylor PR, Sladen GE, Owen WJ (1987) Cricopharyngeal Crohn’s disease. Postgrad Med J 63(746):1101–1102
  39. Russel Maurice G. V. M., Volovics Alexander, Schoon Eric J., van Wijlick Erik H. J., Logan Richard F., Shivananda Shiva, Stockbriigger Reinhold W., Inflammatory Bowel Disease: Is There Any Relation Between Smoking Status and Disease Presentation? : , 10.1097/00054725-199808000-00002
  40. Talbot T, Jewell L, Schloss E, Yakimets W, Thomson AB (1984) Cheilitis antedating Crohn’s disease: case report and literature update of oral lesion. J Clin Gastroenterol 6(4):349–354
  41. Targan Stephan R, Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy, 10.1155/2000/409396
  42. Ulnick KM, Perkins J (2001) Extraintestinal Crohn’s disease: case report and review of the literature. Ear Nose Throat J 80(2):97–100
  43. Van de Scheur MR, van der Waal RI, van Bodegraven AA, Volker-Dieben HJ, Starink TM, van der Waal I (2002) Cheilitis granulomatosa and optic neuropathy as rare extraintestinal manifestations of Crohn’s disease. J Clin Gastroenterol 34(5):557–559
  44. Van Heel DA, McGovern DP, Jewell DP (2001) Crohn’s disease: genetic susceptibility, bacteria, and innate immunity. Lancet 357(9272):1902–1904
  45. Venail F, Garrel R, Corpelet D, Mondain M, Makeieff M, Guerrier B, Chanez P, Crampette L (2002) Nasal involvement in Crohn’s disease: report of a case and diagnostic difficulties of systemic diseases affecting the nose. Rev Laryngol Otol Rhinol (Bord) 123(3):179–184
  46. Wilder WM, Slagle GW, Hand AM, Watkins WJ (1980) Crohn’s disease of the epiglottis, aryepiglottic folds, anus, and rectum. J Clin Gastroenterol 2(1):87–91
  47. Yang J, Maronian N, Reyes V, Waugh P, Brentnall T, Hillel A (2002) Laryngeal and other otolaryngologic manifestations of Crohn’s disease. J Voice 16(2):278–282
Bibliographic reference Eloy, Philippe ; Leruth, Elisabeth ; Goffart, Y ; Nollevaux, Marie-Cécile ; Fridman, V ; et. al. Sinonasal involvement as a rare extraintestinal manifestation of Crohn's disease.. In: European Archives of Oto-Rhino-Laryngology, Vol. 264, no. 1, p. 103-108 (2007)
Permanent URL http://hdl.handle.net/2078.1/26886